Cashu
Request for Content to Summarize Regarding NuCana plc
19 days ago
Stocks
Health Care
ncna
NuCana plc
NCNA
-0.00 (-5.13%)
0.0536
USD
At close at Jul 03, 20:43 UTC
Overview
Loading chart...
Key Stats
Market Cap
211.46K
Dividend Yield
0.00%
P/E Ratio
-0.01
EPS
-10.58
Revenue
-
Avg. Volume
351.93K
About
What does NCNA do?
NuCana PLC is a UK-based biopharmaceutical company focused on cancer treatments using ProTide technology, with candidates NUC-3373 and NUC-7738 currently in Phase I/II clinical trials. The company's pipeline also includes Acelari, a ProTide transformation of gemcitabine.
Join our newsletter to keep up to date with us!
